National Asset Management, Inc. Bio Rad Laboratories, Inc. Transaction History

National Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$359.49 - $486.4 $290,108 - $392,524	807 New	807 $305,000
Q1 2022 May 02, 2022	SELL	$524.57 - $735.42 $318,938 - $447,135	-608 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$708.84 - $794.68 $20,556 - $23,045	29 Added 5.01%	608 $460,000
Q3 2021 Nov 16, 2021	BUY	$657.71 - $825.77 $167,716 - $210,571	255 Added 78.7%	579 $432,000
Q2 2021 Aug 10, 2021	BUY	$576.64 - $649.04 $186,831 - $210,288	324 New	324 $209,000
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $503,796 - $610,024	-921 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$510.68 - $643.45 $22,469 - $28,311	44 Added 5.02%	921 $538,000
Q3 2020 Nov 09, 2020	BUY	$454.43 - $535.6 $28,629 - $33,742	63 Added 7.74%	877 $453,000
Q2 2020 Jul 31, 2020	BUY	$334.87 - $493.06 $15,738 - $23,173	47 Added 6.13%	814 $368,000
Q1 2020 May 06, 2020	BUY	$320.01 - $409.07 $2,880 - $3,681	9 Added 1.19%	767 $270,000
Q4 2019 Feb 10, 2020	BUY	$319.73 - $374.2 $242,355 - $283,643	758 New	758 $282,000

479

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.53B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.